ProStrakan Group plc is one of the UK's fastest growing pharmaceutical companies with commercial operations throughout Europe.

Our primary focus is developing prescription medicines for the treatment of unmet medical needs. Where other companies aren’t able to address these conditions, or choose not to, we create important therapies in order to make a meaningful difference in the lives of patients and their families. In the United States, we will be focusing initially in the product areas of chemotherapy-induced nausea and vomiting (CINV), men's health, and pain relief.

Read our latest developments.
Learn about ProStraCARE™.